These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15186321)

  • 1. Serum levels of manganese superoxide dismutase in patients with localized scleroderma.
    Jinnin M; Ihn H; Yazawa N; Asano Y; Yamane K; Tamaki K
    Exp Dermatol; 2004 Jun; 13(6):357-60. PubMed ID: 15186321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
    J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
    Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.
    Mimra Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
    Int J Dermatol; 2005 Oct; 44(10):817-20. PubMed ID: 16207181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma.
    Kikuchi K; Sato S; Kadono T; Ihn H; Takehara K
    Arch Dermatol; 1994 Oct; 130(10):1269-72. PubMed ID: 7944508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction of manganese superoxide dismutase in ovarian carcinoma].
    Ishikawa M; Nakata T; Shimizu T; Taniguchi N
    Rinsho Byori; 1992 Apr; 40(4):359-62. PubMed ID: 1593761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid factor isotypes in localized scleroderma.
    Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
    Clin Exp Dermatol; 2005 Jul; 30(4):405-8. PubMed ID: 15953082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of manganese superoxide dismutase in ovarian carcinoma].
    Ishikawa M; Hayashi H; Saitoh S; Shimizu T; Yamashita K; Saitoh Y; Kanemoto T; Domon H; Kamiya H; Endoh Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):509-15. PubMed ID: 2056226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum manganese-superoxide dismutase in patients with neuromuscular disorders as judged by an ELISA.
    Yahara O; Hashimoto K; Taniguchi N; Ishikawa M; Sato Y; Yamashita H; Ohno H
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):315-26. PubMed ID: 1947435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between soluble intercellular adhesion molecule 1 level and extracellular superoxide dismutase activity in rheumatoid arthritis: a possible association with disease activity.
    Ugur M; Yildirim K; Kiziltunc A; Erdal A; Karatay S; Senel K
    Scand J Rheumatol; 2004; 33(4):239-43. PubMed ID: 15370719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized scleroderma: a series of 52 patients.
    Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
    Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes.
    Savas HA; Gergerlioglu HS; Armutcu F; Herken H; Yilmaz HR; Kocoglu E; Selek S; Tutkun H; Zoroglu SS; Akyol O
    World J Biol Psychiatry; 2006; 7(1):51-5. PubMed ID: 16428220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay for human manganese-containing superoxide dismutase and its content in lung cancer.
    Iizuka S; Taniguchi N; Makita A
    J Natl Cancer Inst; 1984 May; 72(5):1043-9. PubMed ID: 6585582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma.
    Ishikawa M; Yaginuma Y; Hayashi H; Shimizu T; Endo Y; Taniguchi N
    Cancer Res; 1990 Apr; 50(8):2538-42. PubMed ID: 2317833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum hyaluronan levels in systemic sclerosis: association with disease severity.
    Yoshizaki A; Iwata Y; Komura K; Hara T; Ogawa F; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Sep; 35(9):1825-9. PubMed ID: 18688912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of manganese superoxide dismutase in patients with eosinophilic fasciitis.
    Jinnin M; Ihn H; Yazawa N; Asano Y; Yamane K; Tamaki K
    Clin Rheumatol; 2003 Dec; 22(6):505. PubMed ID: 14677046
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigen specificity of antihistone antibodies in localized scleroderma.
    Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
    Arch Dermatol; 1994 Oct; 130(10):1273-7. PubMed ID: 7524451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
    Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma.
    Nagai M; Hasegawa M; Takehara K; Sato S
    J Invest Dermatol; 2004 Mar; 122(3):594-601. PubMed ID: 15086540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.